-
摘要:
目的 分析陕西省新型冠状病毒肺炎(coronavirus disease 2019, COVID-19)疫情流行特征, 为更好地防控疫情提供参考依据。 方法 从陕西省卫生健康委员会官网上收集全省COVID-19病例个案资料, 采用描述性流行病学方法进行分析。 结果 截至2020年3月15日, 全省共报告COVID-19病例245例(男131例, 女114例), 含输入病例116例(有湖北旅居史者97例), 本地续发病例114例, 无明确接触史者15例; 死亡2例。共报告46起聚集性疫情, 家庭聚集性疫情占84.78%(39/46)。两次疫情高峰分别出现在1月27日(20例)和1月31日(18例)。西安市报告病例占全省48.98%(120/245)。40~岁病例最多(60例)。病例发病到首诊时间为1.0 (0.5, 3.0) d, 首诊到确诊为4.0(3.0, 6.0) d, 发病到确诊为6.0(4.0, 9.0) d。本地病例发病到确诊时间(7 d)较输入病例(5 d)长; 首诊前服药病例发病到确诊时间(9 d)较未服药病例(6 d)长; 首诊选择社区医院病例首诊到确诊时间(7 d)较二级(3 d)、三级(4 d)医院病例长。 结论 陕西省COVID-19疫情分为输入病例为主和本地病例为主两个阶段, 家庭聚集性是其重要特征。病例感染来源, 首诊前是否服药和首诊医院级别可影响疾病确诊。 Abstract:Objective To analyze the epidemiological characteristics of 245 confirmed cases of coronavirus disease 2019(COVID-19) in Shaanxi Province, so as to provide reference for the prevention and control of COVID-19. Methods The data of confirmed cases of COVID-19 obtained from the official website of Shaanxi Province health commission were analyzed by descriptive epidemiological analysis. Results Totally 245 cases(131 male and 114 female) were reported, including 114 indigenous cases, 116 imported cases(97 with sojourn history of Hubei Province), 15 cases without clear infectious sources and 2 deaths. Totally 46 clusters of COVID-19 were reported, while 39 were family clusters(84.78%, 39/46). The results showed that there were 2 peaks of epidemic curve occurred on January 27 th(20 cases) and January 31 th(18 cases), 2020, respectively. Xi'an city reported the most cases of COVID-19, accounting for 48.98%(120/245). The age group of 40-years old reported the most cases, with 60 cases. The median days were 1.0(0.5, 3.0) d from onset to the first-diagnosis, 4.0(3.0, 6.0) d from the first-diagnosis to confirmation and 6.0(4.0, 9.0) d from onset to confirmed diagnosis. The median days from onset to confirmed diagnosis of indigenous cases(7 d) and self-treatment cases(9 d) were longer than that of imported cases(5 d) and no self-treatment cases(6 d), respectively. The median day from the first-diagnosis to confirmation of the cases first-diagnosed in community hospitals(7 d) was longer than that of the cases first-diagnosed in secondary(3 d) or tertiary(4 d) hospitals. Conclusions The epidemic of Shaanxi Province was divided into two stages, characterized by familial clusters. The infectious source of cases, with or without self-treatment before the first-diagnosis and the grade of first-diagnosis hospitals were factors that affected the confirmation of the cases. -
Key words:
- COVID-19 /
- Epidemiological characteristics /
- Cluster epidemic
-
表 1 陕西省COVID-19聚集性疫情发生情况
Table 1. Different types of COVID-19 clusters in Shaanxi Province
感染来源 类型 疫情起数(起) 涉及病例总数(例) 续发病例数(例) 湖北病例输入 家庭聚集性 21 78 39 非湖北病例输入 家庭聚集性 3 13 9 接触湖北疑似病例 家庭聚集性 10 27 27 源头暂时不明 家庭聚集性 5 14 14 源头暂时不明 场所暂时不明 1 2 2 接触湖北疑似病例 场所暂时不明 2 4 4 源头暂时不明 商场 3 12 12 接触湖北疑似病例 集体聚会 1 4 4 合计 46 154 111 -
[1] Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)and coronavirus disease-2019(COVID-19): the epidemic and the challenges[J]. Int J Antimicrob Agents, 2020, 55(3): 105924.DOI: 10. 1016/j. ijantimicag. 2020. 105924. [2] 中华人民共和国国家卫生健康委员会.新型冠状病毒感染的肺炎纳入法定传染病管理[EB/OL]. (2020-01-20)[2020-03-20]. http://www.nhc.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml.National Health Commission of the People's Republic of China. The novel coronavirus pneumonia to be included in the administration of Notifiable diseases[EB/OL]. (2020-01-20)[2020-03-20]. http://www.nhc.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml. [3] WHO. Statement on the second meeting of the international health regulations(2005)emergency committee regarding the outbreak of novel coronavirus(2019-nCoV)[EB/OL]. (2020-01-30)[2020-03-20]. https://www.who.int/news-room/detail/. [4] WHO. WHO director-general's opening remarks at the media briefing on COVID-19-11 March 2020[EB/OL]. (2020-03-11)[2020-03-20]. https://www.who.int/zh/dg/speeches/detail/. [5] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(第六版)[EB/OL]. (2020-02-18)[2020-03-20]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.National Health Commission of the People's Republic of China. The diagnosis and treatment plan for 2019-nCoV(edition sixth)[EB/OL]. (2020-02-18)[2020-03-20]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. [6] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎防控方案(第五版)[EB/OL]. (2020-02-21)[2020-03-20]. http://www.nhc.gov.cn/jkj/s3577/202002/a5d6f7b8c48c451c87dba14889b30147.shtml.National Health Commission of the People's Republic of China. Management plan for prevention and control of novel coronavirus pneumonia(edition fifth)[EB/OL]. (2020-02-21)[2020-03-20]. http://www.nhc.gov.cn/jkj/s3577/202002/a5d6f7b8c48c451c87dba14889b30147.shtml. [7] 陕西省人民政府.陕西启动突发公共卫生事件Ⅰ级应急响应[EB/OL]. (2020-01-26)[2020-03-20]. http://www.shaanxi.gov.cn/sxxw/sxyw/159595.html.The Government of Shaanxi Province. The government of Shaanxi Province started the first level emergency response system for public health emergencies[EB/OL]. (2020-01-26)[2020-03-20].http://www.shaanxi.gov.cn/sxxw/sxyw/159595.html. [8] 林君芬, 吴梦娜, 吴昊澄, 等.浙江省新型冠状病毒肺炎病例流行特征分析[J].预防医学, 2020, 32(3): 217-221, 225.DOI: 10. 19485/j. cnki. issn2096-5087. 2020. 03. 001.Lin JF, Wu MN, Wu HC, et al. Epidemiological characteristics of coronavirus diseases 2019 in Zhejiang Province[J]. Prev Med, 2020, 32(3): 217-221, 225. DOI: 10. 19485/j. cnki. issn2096-5087. 2020. 03. 001. [9] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志, 2020, 41(2): 145-151.DOI: 10. 3760/cma. j. issn. 0254-6450. 2020. 02. 003.Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases(COVID-19)in China[J]. Chin J Epidemiol, 2020, 41(2): 145-151. DOI: 10. 3760/cma. j. issn. 0254-6450. 2020. 02. 003. [10] Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster[J]. Lancet, 2020, 395(10223): 514-523.DOI: 10. 1016/S0140-6736(20)30154-30159.